Literature DB >> 2414847

Circumsporozoite protein of Plasmodium vivax: gene cloning and characterization of the immunodominant epitope.

D E Arnot, J W Barnwell, J P Tam, V Nussenzweig, R S Nussenzweig, V Enea.   

Abstract

The gene encoding the circumsporozoite (CS) protein of the human malaria parasite Plasmodium vivax has been cloned. The deduced sequence of the protein consists of 373 amino acids with a central region of 19 tandem repeats of the nonapeptide Asp-Arg-Ala-Asp/Ala-Gly-Gln-Pro-Ala-Gly. A synthetic 18-amino acid peptide containing two tandem repeats binds to a monoclonal antibody directed to the CS protein of Plasmodium vivax and inhibits the interaction of this antibody with the native protein in sporozoite extracts. The portions of the CS gene that do not contain repeats are closely related to the corresponding regions of the CS genes of two simian malarias, Plasmodium cynomolgi and Plasmodium knowlesi. In contrast, the homology between the CS genes of Plasmodium vivax and Plasmodium falciparum, another malaria parasite of humans, is very limited.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2414847     DOI: 10.1126/science.2414847

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  70 in total

1.  Experimental infection of Anopheles sinensis with Korean isolates of Plasmodium vivax.

Authors:  H W Lee; S H Cho; E H Shin; J S Lee; J S Lee; J Y Chai; S H Lee; T S Kim
Journal:  Korean J Parasitol       Date:  2001-06       Impact factor: 1.341

2.  Two new genotypes of Plasmodium vivax circumsporozoite protein found in the Republic of Korea.

Authors:  W G Kho; Y H Park; J Y Chung; J P Kim; S T Hong; W J Lee; T S Kim; J S Lee
Journal:  Korean J Parasitol       Date:  1999-12       Impact factor: 1.341

3.  Isolation and serological characterization of a Plasmodium vivax recombinant antigen.

Authors:  Y D Sharma; V P Sharma; P Ray; S Laal; S D Sawant; S Verma
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

Review 4.  Reflections on early malaria vaccine studies, the first successful human malaria vaccination, and beyond.

Authors:  Jerome P Vanderberg
Journal:  Vaccine       Date:  2008-10-28       Impact factor: 3.641

Review 5.  Platform for Plasmodium vivax vaccine discovery and development.

Authors:  Sócrates Herrera Valencia; Diana Carolina Rodríguez; Diana Lucía Acero; Vanessa Ocampo; Myriam Arévalo-Herrera
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

6.  Differential susceptibilities of Anopheles albimanus and Anopheles pseudopunctipennis to infections with coindigenous Plasmodium vivax variants VK210 and VK247 in southern Mexico.

Authors:  L Gonzalez-Ceron; M H Rodriguez; J C Nettel; C Villarreal; K C Kain; J E Hernandez
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

7.  Partial protection against Plasmodium vivax blood-stage infection in Saimiri monkeys by immunization with a recombinant C-terminal fragment of merozoite surface protein 1 in block copolymer adjuvant.

Authors:  C Yang; W E Collins; J S Sullivan; D C Kaslow; L Xiao; A A Lal
Journal:  Infect Immun       Date:  1999-01       Impact factor: 3.441

8.  Detection of latent sequence periodicities.

Authors:  E Pizzi; S Liuni; C Frontali
Journal:  Nucleic Acids Res       Date:  1990-07-11       Impact factor: 16.971

9.  Plasmodium vivax circumsporozoite genotypes: a limited variation or new subspecies with major biological consequences?

Authors:  Wanessa C Souza-Neiras; Luciane M Storti-Melo; Gustavo C Cassiano; Vanja S C A Couto; Alvaro A R A Couto; Irene S Soares; Luzia H Carvalho; Maristela G Cunha; Marinete M Póvoa; Socrates Herrera; Myriam A Herrera; Andrea R M Rossit; Claudia M A Carareto; Ricardo L D Machado
Journal:  Malar J       Date:  2010-06-23       Impact factor: 2.979

Review 10.  Plasmodium vivax: who cares?

Authors:  Mary R Galinski; John W Barnwell
Journal:  Malar J       Date:  2008-12-11       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.